Company Overview
About Tamarind Bio
Tamarind Bio is a San Francisco-based computational biology platform — backed by Y Combinator (W24) with $14.1 million raised including a $500,000 seed in 2024 and a $13.6 million Series A in May 2025 — providing pharmaceutical companies, biotechs, and academic researchers with no-code API access to advanced computational biology tools (AlphaFold protein structure prediction, antibody engineering models, protein-protein interaction prediction, molecular dynamics simulation) that historically required high-performance computing infrastructure, specialized bioinformatics expertise, and weeks of computational time to run. Founded in 2023 with a 7-person team, Tamarind serves thousands of researchers across large pharma companies, biotech startups, and academic institutions that need computational biology capabilities without building or maintaining HPC infrastructure.
Business Model & Competitive Advantage
Tamarind's no-code bioinformatics API abstracts the computational biology complexity that prevents wet lab biologists from accessing the transformative machine learning tools their field has developed: a medicinal chemist at a biotech who needs to predict how a protein mutation affects antibody binding affinity can submit a sequence and get structure-informed binding predictions via API within minutes — without knowing how to run AlphaFold on a GPU cluster, configure molecular dynamics software, or interpret raw simulation output files. The platform provides pre-validated workflows ('antibody optimization,' 'epitope mapping,' 'off-target binding prediction') that translate researcher questions into the appropriate computational methods and return results in interpretable formats (binding probability scores, structural visualization, ranked variant libraries). This democratization of computational biology accelerates drug discovery timelines by enabling faster hypothesis testing without specialized bioinformatics team involvement.
Competitive Landscape 2025–2026
In 2025, Tamarind Bio competes in the computational biology SaaS and AI drug discovery tools market with Schrödinger (NASDAQ: SDGR, physics-based molecular simulation software, $500M+ revenue), Dotmatics (scientific software, $900M Insight acquisition), and Benchling (life sciences R&D software, $200M raised at $6.1B valuation) for pharmaceutical computational biology platform adoption. The computational biology market has been transformed by AlphaFold (DeepMind's protein structure prediction breakthrough) and the subsequent wave of structure-informed drug design — companies that can rapidly predict protein structure and model drug-protein interactions computationally reduce the experimental cycles that previously required months of crystallography or cryo-EM. Y Combinator W24 backing positions Tamarind at the intersection of AI and drug discovery that has attracted significant investment. The 2025 strategy focuses on growing pharmaceutical company API subscriptions for large-scale virtual screening campaigns, building the antibody engineering workflow for biologics development teams, and expanding academic institution access through consortium licensing for non-commercial research.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Tamarind Bio is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Zeffy
Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs
Oda Studio
Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Compare Tamarind Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Tamarind Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Tamarind Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Tamarind Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →